Aeluma, a semiconductor company specializing in AI photonics, reported a Q4 earnings per share of -$0.15, missing estimates, but surpassed revenue expectations with $0.582 million. The company’s annual revenue of $4.50 million, mainly from government contracts, remained stable year-over-year. Strategic partnerships, including a $30 million Letter of Intent with the Department of Commerce and a deal with Sumitomo Chemical, aim to boost production capacity for AI markets. With low debt and strong liquidity, Aeluma is positioned for growth despite current losses typical of early-stage companies.
Aeluma, an AI photonics pioneer, is presented here with context from the Technology sector on Pluang. For readers following technology stocks, as of Sep 17, 2026 18:31 WIB, 124 of 150 priced US tech stocks rose while 22 fell. Notable movers include HUT at USD 93.99 with a 4.64% increase and a typical hold time of 10 days, WULF at USD 16.02 up 4.09% with 15 days hold, and VRT at USD 248.18 rising 3.66% with a 35-day hold time, all showing strong buy interest on Pluang.
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
Fieldstone Bio, a synthetic biology company, was selected for the Mining Tech Accelerator program by Founders Factory and Rio Tinto. The program supports innovative technologies that improve mineral exploration and extraction, providing Fieldstone wi...
Dividend 15 Split Corp. has renewed its at-the-market (ATM) equity program, allowing it to issue shares to the public at prevailing market prices until November 7, 2028. This program replaces the previous one that ended in 2025 and enables the compan...
